Screener
West Pharmaceutical Services WST Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
| (in millions, except per share data) | June 30,2026 | December 31,2025 |
|---|---|---|
| Long-term debt | 202.9 | 202.8 |
| Deferred income taxes | 22.4 | 23.0 |
| Pension and other postretirement benefits | 28.3 | 29.0 |
| Operating lease liabilities | 88.3 | 95.6 |
| Deferred compensation benefits | 13.9 | 13.5 |
| Other long-term liabilities | 89.9 | 75.2 |
| Total Liabilities | 1,086.2 | 1,094.0 |
| Commitments and contingencies (Note 16) |
Item 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is West Pharmaceutical Services's operating lease liabilities?
- West Pharmaceutical Services (WST) reported operating lease liabilities of $88.3M in Q2 2026.
- How has West Pharmaceutical Services's operating lease liabilities changed year-over-year?
- West Pharmaceutical Services's operating lease liabilities increased by 10.7% year-over-year, from $79.8M to $88.3M.
- What is the long-term trend for West Pharmaceutical Services's operating lease liabilities?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's operating lease liabilities has grown at a 9.6% compound annual growth rate (CAGR), from $60.4M to $95.6M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about West Pharmaceutical Services's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude